Recent Headlines
Colorado's Bioscience Discovery Evaluation Grant Program Creates 598 New Jobs in the State, with Payroll Exceeding $44 million
The Colorado BioScience Association (CBSA) and The Colorado Office of Economic Development and International Trade (OEDIT) have jointly released results of the Bioscience Discovery Evaluation Grant Program (BDEGP) at the CBSA's Third Annual "Bioscience Day at the Capitol" event. The BDEGP was created by the Colorado General Assembly in 2006 to grow the bioscience industry in the state. - February 05, 2011 - Colorado BioScience Association
Oncolytics Biotech® Inc. Announces 2-Arm, Randomized Phase II Pancreatic Cancer Study
Oncolytics Biotech Inc. (“Oncolytics”) announced that the Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, U.S. National Cancer Institute (NCI), which is part of the National Institutes of Health, has agreed to sponsor a 2-Arm randomized Phase II study of... - February 04, 2011 - Oncolytics Biotech
Pacific Biomarkers Names Sheri’ DuMond as Its New Director of Business Development
Pacific Biomarkers, Inc. (PBI) (OTCBB: PBMC), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, has promoted Sheri’ DuMond to Director of Business Development following her role as Senior Associate Director of Business Development at... - February 04, 2011 - Pacific Biomarkers Inc
Searchable Proposition 65 Chemical Database Released by Columbia Analytical
Columbia Analytical Services, Inc. announces a new website service that allows users to search the California Proposition 65 (Prop 65) chemical list online. The database of 775 chemicals is searchable by a CAS registry number or by the chemical name and when clicked, shows the risk level, maximum... - February 02, 2011 - Columbia Analytical Services
World's Largest Gathering of Stem Cell Patients to be Held in Naples Florida This Saturday
Regenocyte Therapeutic, a worldwide leader in adult stem cell therapy, is hosting an appreciation luncheon for more than 35 of its patients this Saturday – the largest-ever gathering of people treated with adult stem cells. What: Regenocyte Stem Cell Patient Luncheon When: Saturday, January... - January 29, 2011 - Regenocyte Therapeutic
Susan Schniepp, VP of Quality at OSO BioPharmaceuticals, Elected to PDA Board of Directors
Susan Schniepp, vice president of quality at OSO BioPharmaceuticals Manufacturing, LLC, has been elected to the board of directors at the Parenteral Drug Association (PDA). Schniepp has enjoyed a long and productive relationship with the PDA. In addition to serving on numerous committees and being... - January 28, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
OSO BioPharmaceuticals Taps Craig Mastenbaum to Lead West Coast Business Development
OSO BioPharmaceuticals Manufacturing, LLC, has named Craig Mastenbaum director of new business development for its West Coast market. Mastenbaum brings to OsoBio more than 30 years of leadership experience in clinical and contract liquid, lyophilized, ampule and syringe product manufacturing. Most... - January 21, 2011 - OSO BioPharmaceuticals Manufacturing, LLC
Mitegen Appoints New CEO
Mitegen LLC (“Mitegen”, the “Company), a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced today that Robert Newman has been appointed... - January 19, 2011 - MiTeGen, LLC
Laboratory Robotics Interest Group (LRIG) Exhibits at LabAutomation
The Laboratory Robotics Interest Group (LRIG) is pleased to announce its participation in LabAutomation2011, January 29 - February 2, 2011, Palm Springs Convention Center, Palm Springs, California. All conferees, exhibitors, and media are invited to visit the LRIG booth, #492 to get the latest... - January 17, 2011 - Laboratory Robotics Interest Group (LRIG)
Oncolytics Biotech® Inc. Announces Opening of Enrollment in U.S. Phase I Colorectal Cancer Study
The principal investigator of the new colon cancer trial using Reolysin is Dr. Sanjay Goel of the Montefiore Medical Center at The Albert Einstein College of Medicine in New York. - January 13, 2011 - Oncolytics Biotech
Pacific Biomarkers, Inc. Announces Awards of Major Research Contracts
Pacific Biomarkers, Inc. (OTCBB: PBMC, “PBI”), a provider of biomarker laboratory services to the pharmaceutical, biotechnology and diagnostics industries, announced today that it has been awarded two major research contracts with two multinational pharmaceutical companies (the... - January 13, 2011 - Pacific Biomarkers Inc
MRSA Infected Mesh Successfully Treated with Triticum's L-Mesitran Honey Ointment
The overall reported percentage of mesh infections is 1.3%. Infections after incisional ventral hernia repair depend on many factors. Salvaging an infected mesh should be the priority, because serious complications are reported following mesh removal. Dr Chatzoulis et al. reports a case report and... - January 12, 2011 - Mesitran
ALPCO Appoints Cosmo Bio Co., Ltd. as Their New Distribution Channel in Japan
Cosmo Bio Co., Ltd. is a distributor of high quality research reagents and instruments throughout Japan. ALPCO Diagnostics is a leading developer and distributor of high quality immunoassay kits in the US. The two companies feel that their mutual commitment to offering quality products in the life science research area will be the basis for a strong partnership. - January 10, 2011 - ALPCO
Corengi Diabetes Clinical Trial Website Trades Facebook "Likes" for Donations to Dodging Diabetes® Charity
Corengi campaign helps patients living with Type 2 diabetes select clinical trials and supports diabetes research. - January 05, 2011 - Corengi, Inc.
Affinity Life Sciences Announces Expansion of Their cGMP Manufacturing Facility to Provide Additional Capacity for Biomarker Assay Development and Lyophilization Services
Affinity Life Sciences, Inc. is a New England based contract manufacturing and research organization committed to providing scientific and quality expertise to meet the unique production demands of the biotechnology and pharmaceutical industries worldwide. Affinity's introduction of this space allows for even greater capacity and efficiency for projects ranging from R&D to cGMP compliant production. - December 31, 2010 - Affinity Life Sciences
Achieve Clinical Research Announces Chronic Pain Research Studies in Birmingham, Alabama
Achieve Clinical Research conducts Phase II-IV clinical research studies on many conditions. Located in Birmingham, near Vestavia, Homewood, and North Jefferson. Participation can include medical care. - December 23, 2010 - Achieve Clinical Research
Latest Research Confirms That Triticum's L-Mesitran Honey Products Show Antibacterial Efficacy Against Antibiotic Resistant Bacteriae
Honey based products for wound care proved to be highly effective against strains of antibiotic bacteriae including ESBL. - December 16, 2010 - Mesitran
Achieve Clinical Research Announces Asthma Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with asthma. - December 12, 2010 - Achieve Clinical Research
Interest in Sclerostin as a Regulator of Bone Formation Remains High
Sclerostin, a protein produced primarily in osteocytes, inhibits osteoblast activity via antagonism of the wnt signaling pathway and, as such, has garnered a great deal of attention as a potential therapeutic target for increasing bone formation. The annual publication rate for peer-reviewed... - December 07, 2010 - ALPCO
Clinical Trials of America Opens New Site in Seattle and Names Kathy Hendricks as Manager
Clinical Trials of America Inc. has announced the opening of a new Seattle site and named Kathy Hendricks as site manager. Hendricks leads operational and business development and oversees patient recruitment and relations. “The opening of the Seattle site is the next phase of expansion for... - December 02, 2010 - Clinical Trials of America
Leeds Scientific to Unveil New Distributor Opportunities for Sculptisse
Leeds Scientific has patented their most popular product Sculptisse, and is now offering exclusive distributorships worldwide. - December 02, 2010 - Leeds Scientific
Leeds Scientific Wins Approval in France
Savvy French consumers and distributors alike have praised Sculptisse for having powerful results that safely and effectively eliminates wrinkles faster than most wrinkle creams on the market. - December 01, 2010 - Leeds Scientific
Medlabusa.com, STD Test & STD Testing with No Doctor’s Prescription
www.medlabusa.com, an online medical testing site, announced today that it has completed work and launched a new website, aimed at lowering rapidly escalating medical testing costs, with no doctor’s prescription. Doctor owned/operated www.medlabusa.com, is a new concept that allows anyone to... - November 30, 2010 - Medlabusa.com
Achieve Clinical Research Announces Irritable Bowel Syndrome Research Studies in Birmingham, Alabama
Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with irritable bowel syndrome (IBS). - November 24, 2010 - Achieve Clinical Research
Dilyx Launches New Kit for Improved Protein Solubility
Dilyx Biotechnologies, LLC announces the launch of the OptiSol Protein Solubility Screening Kit, allowing research scientists to aggregation-proof their protein samples. The resulting data saves effort and money because it informs life science researchers on how to best treat specific samples for storage or analysis. Find more information at www.dilyx.com - November 19, 2010 - Dilyx Biotechnologies
Calvert Research Awarded Federal Grants Totaling Approximately $245,000 to Support Further Development of Its Age-Related Macular Degeneration Drug Candidate
Calvert Research, LLC announced today that one of the Company’s therapeutic development programs (T1-1081) qualified to receive federal grant funding totaling approximately $245,000 under the Patient Protection and Affordable Care Act of 2010 (“The ACT”), which will be used to... - November 17, 2010 - Calvert Research
Achieve Clinical Research Announces Influenza Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with influenza. - November 14, 2010 - Achieve Clinical Research
NanoCor Therapeutics, Inc. is Awarded a Grant Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP)
NanoCor Therapeutics, Inc. (NanoCor) today announced the Company was awarded a grant under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP). The grant is being provided under section 48D of the Internal Revenue Code, enacted as part of the Patient Protection and Affordable Care... - November 08, 2010 - NanoCor Therapeutics Inc.
Colorado’s Bioscience Industry Awarded Over $23 Million in Funding from Federal Qualifying Therapeutic Discovery Project Grant and Tax Credit Program
According to the Colorado BioScience Association (CBSA), Colorado’s bioscience industry received more than $23 million for 102 different projects in the Qualifying Therapeutic Discovery Project (QTDP) program, per data posted online Monday by the Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services (HHS). Colorado ranks in the top ten of states applying for credits and grants under the new program. - November 06, 2010 - Colorado BioScience Association
Clinical Trials of America, Inc., Participating in Pivotal Clinical Study of Novel Treatment for Type 1 Diabetes
Defend-2 Evaluating Drug Candidate, Otelixizumab, in New-Onset Type 1 Diabetes. - November 06, 2010 - Clinical Trials of America
Clinical Trials of America Names Pamela Pannier Clinical Operations Director
Pamela Pannier has joined Clinical Trials of America, Inc., as the company’s clinical operations director. Pannier will lead business development, including sourcing, managing and implementing new business opportunities in the Eugene and surrounding areas. “Pamela Pannier brings almost... - November 06, 2010 - Clinical Trials of America
Achieve Clinical Research Announces Osteoarthritis (OA) Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with osteoarthritis (OA). - November 05, 2010 - Achieve Clinical Research
Patients Use More Specific Keywords While Seeking Clinical Trial Information Online, According to TrialX Research
A new research study finds that e-patients searching for health information related to clinical research studies tend to use longer and more specific keywords - November 04, 2010 - Applied Informatics
Revolutionary Vbeam® Perfecta Laser Treatment for Rosacea and Facial Veins
The Vbeam® Perfecta sets the gold standard in treatment of facial redness such as rosacea and facial veins. It is highly recommended for unsightly broken capillaries, spider hemangioms, telangectasia or skin discoloration on the face. - November 04, 2010 - Abrams Dermatology
Corengi Launches New Web Site to Help Type 2 Diabetes Patients Find Suitable Clinical Trials
www.corengi.com simplifies the clinical trial selection process; enables type 2 diabetes patients to learn which trials are right for them. - October 28, 2010 - Corengi, Inc.
The Colorado BioScience Association and 650+ Partners Oppose Amendments 60 and 61 & Proposition 101
The Colorado BioScience Association along with over 650 partners are opposed to three ballot measures facing Colorado this election – Amendment 60, Amendment 61 and Proposition 101. These three measures - also known as the 'ugly three' - are referred to as tax breaks, but will have a devastating impact on Colorado and the companies located in the state for years to come. - October 27, 2010 - Colorado BioScience Association
Stemedica International Announces Joint Venture with AnC Bio Group to Manufacture Allogeneic Adult Stem Cells
Stemedica International, S.A., a wholly owned subsidiary of Stemedica Cell Technologies, Inc., announced the signing of an agreement to form a joint venture with AnC Bio, a global manufacturer of stem cell-based products. The new venture, StemedicaAnC, will manufacture allogeneic adult stem cells developed by Stemedica for the treatment of ischemic stroke and other degenerative disorders. - October 24, 2010 - Stemedica Cell Techechnologies
Clinical Trials of America Announces Don Dickerson as President
Donald Dickerson, experienced business leader and clinical studies manager, joins Clinical Trials of America as the company’s new president. Dickerson, who has developed and advanced profitable companies and divisions in global health, technology, and financial service, now manages all... - October 22, 2010 - Clinical Trials of America
Colorado BioScience Association and Two of the State’s Economic Development Entities, Tout Colorado’s Strengths at AdvaMed 2010
Representatives from the Colorado BioScience Association, Colorado Office of Economic Development and International Trade and Metro Denver Economic Development Corporation will showcase Colorado’s medical device and diagnostics sectors during the 2010 AdvaMed: The MedTech Conference in Washington D.C., October 18-20. - October 20, 2010 - Colorado BioScience Association
Clinical Trials of America’s CEO & Chief Medical Officer Presents at MAGI’s Clinical Research Conference – 2010 West
Dr. Richard Beyerlein explains how to be a clinical researcher’s “sponsor of choice.” - October 16, 2010 - Clinical Trials of America
Stemedica Announces Completion of Clinical Allogeneic Adult Stem Cell Master Bank
A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells. - October 15, 2010 - Stemedica Cell Techechnologies
Achieve Clinical Research Announces Rheumatoid Arthritis Research Studies in Birmingham, Alabama
Achieve Clinical Research, announces the launch of several research studies to test investigational treatment options for those already diagnosed with rheumatoid arthritis. - October 14, 2010 - Achieve Clinical Research
Creativ-Ceutical to be Centre Stage at ISPOR Europe 2010
Strengthening its positioning as one of the major pan-European consulting companies in pricing, market access and health economics, Creativ-Ceutical will be present in force at ISPOR 2010 from 6-9 November in Prague. - October 13, 2010 - Creativ-Ceutical
Optasia Medical to Demonstrate Innovative X-Ray Analysis Capabilities at Leading Industry Events
Optasia Medical introduces powerful new clinical workflow tools for the interpretation of x-rays for osteoporosis and arthritis - October 12, 2010 - Optasia Medical, Ltd.
Colorado BioScience Association Announces Winners of Its 2010 Awards, Honoring The Best of Colorado's Bioscience Industry
The Colorado BioScience Association (CBSA) honored the outstanding bioscience companies and individuals in the state during its 2010 Annual Awards Dinner held in conjunction with the BioWest Conference & Expo at the Denver Grand Hyatt. The Annual Awards Dinner gives CBSA the ability to showcase companies and individuals that have had an outstanding year and to celebrate the industry as a whole. - October 11, 2010 - Colorado BioScience Association
IonSense Expands Product Line with ASAP Open-Air Ionization Source
IonSense to sell Atmospheric Solids Analysis Probe (ASAP) as Entry Level Source for Open-Air Mass Spectrometry - October 08, 2010 - IonSense, Inc.
Adaptive Site Monitoring Improves Clinical Research Efficiency: DIA Invites Health Decisions to Discuss
Health Decisions CEO Dr. Michael Rosenberg will explore the implications of advanced e-monitoring models during two sessions at the DIA 4th Annual Clinical Forum. - October 08, 2010 - Health Decisions
New to the Medik8 Beta Range – The Anti-Acne Kit
The Medik8 “beta” range is constantly evolving, with 2010 proving to be a pivotal year in the maturing of this award-winning line for problem skin. September 2010 sees the launch of the brand new Anti-Acne Kit. Combining state of the art formulations with on the pulse market focus, Medik8 have designed two unique products to create a convenient dual treatment pack. - October 06, 2010 - Pangaea Ltd.
Introducing Professional PDT from Medik8
Light Amplifier™ RX has been formulated by Medik8 scientists to boost the clinically proven results from increasingly popular light therapy. This novel and unique lightweight 20% strength serum is applied prior to light therapy procedures in-clinic and dramatically increases efficacy of all light-based hardware regardless of manufacturer; a retail version is also available for at-home use with a personal light therapy lamp. - October 06, 2010 - Pangaea Ltd.
Is Medik8® Now Chasing Men with Its Oil-Free Antioxidant Blue Aox™?
Medik8 Skin Research has developed Blue AOX™; a powerful antioxidant serum to put skin aging on hold. - October 06, 2010 - Pangaea Ltd.